| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.007 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.083 | 0.008 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.078 | 0.009 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.009 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.01 |